Potassium 7-hydroxy-1-naphthalenesulfona
CAS No. 30252-40-5
Potassium 7-hydroxy-1-naphthalenesulfona ( 2-Naphthol-8-sulfonic Acid Potassium Salt )
Catalog No. M29440 CAS No. 30252-40-5
Potassium 7-hydroxy-1-naphthalenesulfona is naturally present in the fruit of the Rubiaceae gardenia, the flowers of the Iridaceae crocus, and the flowers and leaves of the Scrophulariaceae Scrophulariaceae.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
50MG | 45 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePotassium 7-hydroxy-1-naphthalenesulfona
-
NoteResearch use only, not for human use.
-
Brief DescriptionPotassium 7-hydroxy-1-naphthalenesulfona is naturally present in the fruit of the Rubiaceae gardenia, the flowers of the Iridaceae crocus, and the flowers and leaves of the Scrophulariaceae Scrophulariaceae.
-
DescriptionPotassium 7-hydroxy-1-naphthalenesulfona is naturally present in the fruit of the Rubiaceae gardenia, the flowers of the Iridaceae crocus, and the flowers and leaves of the Scrophulariaceae Scrophulariaceae.
-
Synonyms2-Naphthol-8-sulfonic Acid Potassium Salt
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number30252-40-5
-
Formula Weight262.3
-
Molecular FormulaC10H7KO4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[K+].Oc1ccc2cccc(c2c1)S([O-])(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
KKI-5
KKI 5 is a serine protease inhibitor that inhibits kallikrein and plasmin. KKI 5 may exhibit anticancer chemotherapeutic benefit and may also be used as a treatment for angioedema.
-
Triacetonamine hydro...
Triacetonamine hydrochloride is a natural product for research related to life sciences.
-
Nogo-66 (1-40)
Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.